The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 73, Issue 6, Pages 1232-1239
Publisher
BMJ
Online
2013-05-23
DOI
10.1136/annrheumdis-2012-203194
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis
- (2012) Christian Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis
- (2012) Christian Beyer et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells
- (2012) Jun Wei et al. ARTHRITIS AND RHEUMATISM
- Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma
- (2012) Jing Zhu et al. CARCINOGENESIS
- SFRP1CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence
- (2012) Faranaz Atschekzei et al. Epigenetics
- DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer
- (2012) Jian Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
- (2012) Alfiya Akhmetshina et al. Nature Communications
- Inhibition of glycogen synthase kinase 3 induces dermal fibrosis by activation of the canonical Wnt pathway
- (2011) C. Bergmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma?
- (2011) Jun Wei et al. ARTHRITIS AND RHEUMATISM
- WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix
- (2011) Amber L. Delmas et al. CARCINOGENESIS
- Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?
- (2011) Astrid Jüngel et al. Expert Review of Clinical Immunology
- Resolving the Scar of Pulmonary Fibrosis
- (2011) Gregory P. Downey NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-29, a key regulator of collagen expression in systemic sclerosis
- (2010) Britta Maurer et al. ARTHRITIS AND RHEUMATISM
- Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer
- (2010) Kazumori Kawakami et al. INTERNATIONAL JOURNAL OF CANCER
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
- (2009) Maya Kansara et al. JOURNAL OF CLINICAL INVESTIGATION
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
- (2008) H Suzuki et al. BRITISH JOURNAL OF CANCER
- Promoter methylation of the Wnt/β-catenin signaling antagonistDkk-3is associated with poor survival in gastric cancer
- (2008) Jun Yu et al. CANCER
- Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
- (2008) Alfiya Akhmetshina et al. FASEB JOURNAL
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation